Literature DB >> 33471214

Interdisciplinary Approaches to Survivorship with a Focus on the Low-grade and Benign Brain Tumor Populations.

Stacey L Worrell1, Michelle L Kirschner2, Rhonna S Shatz1, Soma Sengupta3, Melissa G Erickson2.   

Abstract

PURPOSE OF REVIEW: "Brain tumor is a bump in the road." Sheryl Crow a famous singer was quoted talking about her meningioma, a benign brain tumor that caused her to forget her lyrics. In this review, we focus on low-grade gliomas in adults and benign brain tumors, such as meningiomas, vestibular schwannomas, and pituitary tumors, since these individuals survive a long time and morbidity is a major issue. RECENT
FINDINGS: As per the NCI dictionary definition, cancer survivorship focuses on the health and well-being of a person with cancer from the time of diagnosis until the end of life. This includes the physical, mental, emotional, social, and financial effects of cancer that begin at diagnosis and continue through treatment and beyond. The survivorship experience also includes issues related to follow-up care (including regular health and wellness checkups), late effects of treatment, cancer recurrence, second cancers, and quality of life. Family members, friends, and caregivers are also considered part of the survivorship experience (NCI Dictionary: https://www.cancer.gov/publications/dictionaries/cancer-terms ).

Entities:  

Keywords:  Low-grade gliomas; Meningiomas; Pituitary tumors; Survivorship; Vestibular schwannomas

Mesh:

Year:  2021        PMID: 33471214      PMCID: PMC7817573          DOI: 10.1007/s11912-020-01004-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  37 in total

1.  PREHAB vs. REHAB - presurgical treatment in vestibular schwannoma surgery enhances recovery of postural control better than postoperative rehabilitation: Retrospective case series.

Authors:  Fredrik Tjernström; Per-Anders Fransson; Babar Kahlon; Mikael Karlberg; Sven Lindberg; Peter Siesjö; Måns Magnusson
Journal:  J Vestib Res       Date:  2018       Impact factor: 2.435

2.  Evaluating a 12-week exercise program for brain cancer patients.

Authors:  Lauren C Capozzi; Kevin R Boldt; Jacob Easaw; Barry Bultz; S Nicole Culos-Reed
Journal:  Psychooncology       Date:  2015-05-20       Impact factor: 3.894

3.  National Cancer Institute-American Society of Clinical Oncology Teams in Cancer Care Project.

Authors:  Michael P Kosty; Amy Hanley; Veronica Chollette; Suanna S Bruinooge; Steven H Taplin
Journal:  J Oncol Pract       Date:  2016-10-24       Impact factor: 3.840

4.  Survivorship in Neuro-Oncology.

Authors:  Terri S Armstrong
Journal:  Neuro Oncol       Date:  2018-11-09       Impact factor: 12.300

5.  Trends in hearing rehabilitation use among vestibular schwannoma patients.

Authors:  Madeleine A Drusin; Brienne Lubor; Tasher Losenegger; Samuel Selesnick
Journal:  Laryngoscope       Date:  2019-10-11       Impact factor: 3.325

6.  Analysis of health-related quality of life in patients with brain tumors prior and subsequent to radiotherapy.

Authors:  Claudia Bitterlich; Dirk Vordermark
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

7.  Assessment of neuropsychological parameters and quality of life to evaluate outcome in patients with surgically treated supratentorial meningiomas.

Authors:  Wolfgang Krupp; Christoph Klein; Ronald Koschny; Heidrun Holland; Volker Seifert; Juergen Meixensberger
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

8.  Preoperative and postoperative cognitive functioning in patients with frontal meningiomas.

Authors:  Oliver Tucha; Christian Smely; Michael Preier; Georg Becker; Geraldine M Paul; Klaus W Lange
Journal:  J Neurosurg       Date:  2003-01       Impact factor: 5.115

9.  Cancer Survivorship in Primary Care.

Authors:  Jihun Kang; Eun Ju Park; Jungkwon Lee
Journal:  Korean J Fam Med       Date:  2019-11-20

10.  Tailored exercise interventions to reduce fatigue in cancer survivors: study protocol of a randomized controlled trial.

Authors:  Rosie Twomey; Tristan Martin; John Temesi; S Nicole Culos-Reed; Guillaume Y Millet
Journal:  BMC Cancer       Date:  2018-07-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.